Drug intelligence / Profile preview

nano-hydroquinone

Development stage
Unknown
Lead developer
China-Japan Friendship Hospital
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Topical
01

Overview

Nano-hydroquinone is a specialized topical formulation of the depigmenting agent hydroquinone, developed by the China-Japan Friendship Hospital specifically for the treatment of melasma. By utilizing nanotechnology—typically in the form of nanoemulsions or nanostructured lipid carriers—this formulation addresses the inherent limitations of conventional hydroquinone, such as chemical instability, poor skin penetration, and a high incidence of skin irritation. The mechanism of action involves the potent inhibition of tyrosinase, the rate-limiting enzyme in the melanogenesis pathway, thereby reducing the production of melanin in hyperactive melanocytes. The nano-encapsulation allows for a controlled release of the active ingredient and enhanced delivery to the melanocytes in the basal layer of the epidermis, resulting in improved clinical efficacy and a more favorable safety profile compared to standard hydroquinone preparations.

Brand names
Nano-hydroquinone Cream
Other names
Nano-HQHydroquinone nanoemulsionNano-hydroquinone cream
02

Targets

TYR (Tyrosinase)

Beyond the preview

Go deeper on nano-hydroquinone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nano-hydroquinone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call